Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IκBα, c-Jun and androgen receptor

Pharmazie

Volumn 68, Issue 6, 2013, Pages 431-434

  Guo, Hui ^a   Xu, Yue Min ^a   Ye, Zhang Qun ^b   Yu, Jian Hua ^c   Hu, Xiao Yong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Hubei Provincial Corps Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CURCUMIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C JUN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; DOWN REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MALE; PROSTATE CANCER; UPREGULATION;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CURCUMIN; FLOW CYTOMETRY; G2 PHASE; HUMANS; I-KAPPA B PROTEINS; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84880487998     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2861     Document Type: Article

References (18)

1. Berginc K, Trontelj J, Basnet NS, Kristl A (2012) Physiological barriers to the oral delivery of curcumin. Pharmazie 67: 518-524.
2. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481-488.
3. Brinkmann AO, Trapman J (2000) Prostate cancer schemes for androgen escape. Nat Med 6: 628-629.
4. Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte ON, Said J, Reiter RE, Sawyers CL (1999) Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res 59: 5030-5036.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics 2008. CA Cancer J Clin 58: 71-96.
6. Karin M (1999) How NF-κB is activated: the role of the IκBα kinase (IKK) complex? Oncogene 18: 6867-6874.
7. Kim MH, Yoo DS, Lee SY, Byeon SE, Lee YG, Min T, Rho HS, Rhee MH, Lee J, Cho JY (2011) The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects. Pharmazie 66: 293-300.
8. Ntais C, Polycarpou A, Tsatsoulis A (2003) Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes. Eur J Endocrinol. 149: 469-477.
9. Ostrander EA, Stanford JL (2000) Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 67: 1367-1375.
10. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG (2003) Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 32: 364-371.
11. Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Föller M, Gravanis A, Alevizopoulos K, Lang F, Stournaras C (2008) Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Mol Cancer 7: 88.
12. Park IJ, Kim MJ, Park OJ, Park MG, Choe W, Kang I, Kim SS, Ha J (2010) Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)- mediated apoptosis through Bcl-2 and MAPK regulation. Cancer Lett 298: 88-98.
13. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG (2006) Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6: 107-117.
14. Vogt PK (2001) Jun, the oncoprotein. Oncogene 20: 2365-2377.
15. Wang H, Wang X, Li Y, Liao A, Fu B, Pan H, Liu Z, Yang W (2012) The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. Pharmazie 67: 187-192.
16. Wu LF, Li GP, Su JD, Pu ZJ, Feng JL, Ye YQ, Wei BL (2010) Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells. Biochem. Cell Biol 88: 705-714.
17. Yao J, Duan L, Fan M, Wu X (2006) NF-κB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells. Pharmacol Res 54: 406-413.
18. Yeh HC, Huang CH, Yang SF, Li CC, Chang LL, Lin HH, Ke HL, Wei YC, Wu WJ (2010) Nuclear factor-κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma. BJU Int 106: 1223-1229.